These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30592114)

  • 21. Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity.
    Ohtani K; Fujino T; Ide T; Funakoshi K; Sakamoto I; Hiasa KI; Higo T; Kamezaki K; Akashi K; Tsutsui H
    Clin Res Cardiol; 2019 Jun; 108(6):600-611. PubMed ID: 30367208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
    Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
    Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac complications in childhood cancer survivors treated with anthracyclines.
    Franco VI; Lipshultz SE
    Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
    Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
    Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Traditional Heart Failure Risk Factors on Myocardial Dysfunction in Adult Survivors of Childhood Cancer.
    Nolan MT; Marwick TH; Plana JC; Li Z; Ness KK; Joshi VM; Green DM; Robison LL; Hudson MM; Armstrong GT
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1202-1203. PubMed ID: 29454779
    [No Abstract]   [Full Text] [Related]  

  • 26. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer.
    D'Errico MP; Grimaldi L; Petruzzelli MF; Gianicolo EA; Tramacere F; Monetti A; Placella R; Pili G; Andreassi MG; Sicari R; Picano E; Portaluri M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e239-46. PubMed ID: 21640499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
    Bates JE; Shrestha S; Liu Q; Smith SA; Mulrooney DA; Leisenring W; Gibson T; Robison LL; Chow EJ; Oeffinger KC; Armstrong GT; Constine LS; Hoppe BS; Lee C; Yasui Y; Howell RM
    J Clin Oncol; 2023 Aug; 41(22):3826-3838. PubMed ID: 37307512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
    Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer.
    Yu AF; Raikhelkar J; Zabor EC; Tonorezos ES; Moskowitz CS; Adsuar R; Mara E; Huie K; Oeffinger KC; Steingart RM; Liu JE
    Biomed Res Int; 2016; 2016():9363951. PubMed ID: 26942202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.
    Ylänen K; Eerola A; Vettenranta K; Poutanen T
    Eur J Pediatr; 2016 Oct; 175(10):1379-86. PubMed ID: 27620626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures.
    van den Bogaard VA; Ta BD; van der Schaaf A; Bouma AB; Middag AM; Bantema-Joppe EJ; van Dijk LV; van Dijk-Peters FB; Marteijn LA; de Bock GH; Burgerhof JG; Gietema JA; Langendijk JA; Maduro JH; Crijns AP
    J Clin Oncol; 2017 Apr; 35(11):1171-1178. PubMed ID: 28095159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
    Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.
    Keramida K; Farmakis D; Bingcang J; Sulemane S; Sutherland S; Bingcang RA; Ramachandran K; Tzavara C; Charalampopoulos G; Filippiadis D; Kouris N; Nihoyannopoulos P
    Eur J Heart Fail; 2019 Apr; 21(4):529-535. PubMed ID: 30811091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic Myocardial Response to Exercise in Childhood Cancer Survivors Treated with Anthracyclines.
    Cifra B; Chen CK; Fan CS; Slorach C; Manlhiot C; McCrindle BW; Dragulescu A; Redington AN; Friedberg MK; Nathan PC; Mertens L
    J Am Soc Echocardiogr; 2018 Aug; 31(8):933-942. PubMed ID: 29615292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
    Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
    Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer.
    Krauss DJ; Kestin LL; Raff G; Yan D; Wong J; Gentry R; Letts N; Vargas CE; Martinez AA; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1243-50. PubMed ID: 15752906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced heart failure due to cancer therapy.
    Shah S; Nohria A
    Curr Cardiol Rep; 2015; 17(4):16. PubMed ID: 25687365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma.
    Bini I; Asaftei SD; Riggi C; Tirtei E; Manicone R; Biasin E; Basso ME; Agnoletti G; Fagioli F
    Cardiol Young; 2017 Nov; 27(9):1815-1822. PubMed ID: 28780919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left Ventricular Mass Change After Anthracycline Chemotherapy.
    Jordan JH; Castellino SM; Meléndez GC; Klepin HD; Ellis LR; Lamar Z; Vasu S; Kitzman DW; Ntim WO; Brubaker PH; Reichek N; D'Agostino RB; Hundley WG
    Circ Heart Fail; 2018 Jul; 11(7):e004560. PubMed ID: 29991488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.